Aristolochic acid-induced cell cycle G1 arrest in human urothelium SV-HUC-1 cells

Food and Chemical Toxicology

Volumn 45, Issue 3, 2007, Pages 396-402

  Chang, Horng Rong ^a,b   Lian, Jong Da ^a   Lo, Chia Wen ^b   Huang, Hui Pei ^b   Wang, Chau Jong ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aristolochic acid; Cell cycle arrest; Urothelium

Indexed keywords

ARISTOLOCHIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN EXPRESSION; UROGENITAL TRACT TUMOR; UROTHELIUM;

ARISTOLOCHIC ACIDS; CARCINOGENS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN E; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; G1 PHASE; HUMANS; URINARY BLADDER;

EID: 33846613752     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.08.020     Document Type: Article

References (46)

1. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim. Biophys. Acta 1471 (2001) M123-M133
2. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 60 (2000) 1051-1059
3. Arai T., Watanabe J., Kawaguchi M., Kamata Y., Nishimura Y., Jobo T., and Kuramoto H. Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma. Int. J. Gynecol. Cancer 16 (2006) 391-395
4. Arlt V.M., Schmeiser H.H., and Pfeifer G.P. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR. Carcinogenesis 22 (2001) 133-140
5. Arlt V.M., Stiborova M., and Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17 (2002) 265-277
6. Bartek J., and Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490 (2001) 117-122
7. Chang M.S., Lee H.S., Jung E.J., Kim C.W., Lee B.L., and Kim W.H. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int. J. Oncol. 27 (2005) 1265-1272
8. Chang M.S., Lee H.S., Lee B.L., Kim Y.T., Lee J.S., and Kim W.H. Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol. Res. Pract. 201 (2005) 417-425
9. Christian B.J., Loretz L.J., Oberley T.D., and Reznikoff C.A. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res. 47 (1987) 6066-6073
10. Cosyns J.P., Jadoul M., Squifflet J.P., van Cangh P.J., and van Ypersele d.S.C. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 344 (1994) 188
11. Cosyns J.P., Goebbels R.M., Liberton V., Schmeiser H.H., Bieler C.A., and Bernard A.M. Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats. Arch. Toxicol. 72 (1998) 738-743
12. Cosyns J.P., Jadoul M., Squifflet J.P., Wese F.X., and van Ypersele d.S.C. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 33 (1999) 1011-1017
13. Du Y., Wang X.L., Wu G.X., Wang Y.J., Yang H.C., and Zuo L.F. Flow cytometric detection and significance of four cyclins in esophageal cancer. Zhonghua Zhong Liu Za Zhi. 26 (2004) 612-614
14. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
15. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994) 1169-1174
16. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., and Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98 (1999) 859-869
17. Hirao Y., Kitagawa H., Yoshie T., Futami T., Momose H., Ozono S., and Okajima E. The effects of rhodamine 123 on the cell growth of the cultured cells derived from urogenital carcinoma. Hinyokika Kiyo. 39 (1993) 1233-1240
18. Ioachim E., Michael M., Stavropoulos N.E., Kitsiou E., Hastazeris K., Salmas M., Stefanaki S., and Agnantis N.J. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Urol. Int. 73 (2004) 65-73
19. Itoi T., Shinohara Y., Takeda K., Nakamura K., Takei K., Sanada J., Horibe T., Saito T., Kasuya K., and Ebihara Y. Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J. Gastroenterol. 35 (2000) 142-149
20. Jackson L., Kofman S., Weiss A., and Brodovsky H. Aristolochic acid (NSC-50413): phase I clinical study. Cancer Chemother. Rep. 42 (1964) 3-37
21. Li W.H., Yang L., Su T., Song Y., and Li X.M. Influence of taking aristolochic acid-containing Chinese drugs on occurrence of urinary transitional cell cancer in uremic patients undergoing dialysis. Zhonghua Yi Xue Za Zhi. 85 (2005) 2487-2491
22. Lord G.M., Tagore R., Cook T., Gower P., and Pusey C.D. Nephropathy caused by Chinese herbs in the UK. Lancet 354 (1999) 481-482
23. Mengs U., Lang W., and Poch J.A. The carcinogenic action of aristolochic acid in rats. Arch. Toxicol. 51 (1982) 107-119
24. Mills M., Meysick K.C., and O'Brien A.D. Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun. 68 (2000) 5869-5880
25. Moustakas A., Pardali K., Gaal A., and Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 82 (2002) 85-91
26. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., De Pauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl. J. Med. 342 (2000) 1686-1692
27. Pena J.M., Borras M., Ramos J., and Montoliu J. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. Nephrol. Dial Transplant. 11 (1996) 1359-1360
28. Peters G., and Hedwall P.R. Aristolochic acid intoxication: a new type of impairment of urinary concentrating ability. Arch. Int. Pharmacodyn. Ther. 145 (1963) 334-355
29. Pfau W., Schmeiser H.H., and Wiessler M. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis 11 (1990) 313-319
30. Pfau W., Schmeiser H.H., and Wiessler M. N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. Chem. Res. Toxicol. 4 (1991) 581-586
31. Robisch G., Schimmer O., and Goggelmann W. Aristolochic acid is a direct mutagen in Salmonella typhimurium. Mutat. Res. 105 (1982) 201-204
32. Rossiello M.R., Laconi E., Rao P.M., Rajalakshmi S., and Sarma D.S. Induction of hepatic nodules in the rat by aristolochic acid. Cancer Lett. 71 (1993) 83-87
33. Schmeiser H.H., Pool B.L., and Wiessler M. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 7 (1986) 59-63
34. Schmeiser H.H., Janssen J.W., Lyons J., Scherf H.R., Pfau W., Buchmann A., Bartram C.R., and Wiessler M. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res. 50 (1990) 5464-5469
35. Schmeiser H.H., Bieler C.A., Wiessler M., van Ypersele d.S.C., and Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56 (1996) 2025-2028
36. Stengel B., and Jones E. End-stage renal insufficiency associated with Chinese herbal consumption in France. Nephrologie 19 (1998) 15-20
37. Su P.F., Hu Y.J., Ho I.C., Cheng Y.M., and Lee T.C. Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ. Health Perspect. 114 (2006) 394-403
38. Terauchi F., Okamoto A., Nagashima T., Kobayashi Y., Moritake T., Yamamoto Y., Takakura S., Iwaki S., and Ogura H. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary. Oncol. Rep. 14 (2005) 363-368
39. Vanhaelen M., Vanhaelen-Fastre R., But P., and Vanherweghem J.L. Identification of aristolochic acid in Chinese herbs. Lancet 343 (1994) 174
40. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
41. Vanherweghem J.L., Tielemans C., Simon J., and Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol. Dial Transplant. 10 (1995) 270-273
42. Vidal A., and Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 247 (2000) 1-15
43. Wang L., Liu T., Nishioka M., Aguirre R.L., Win S.S., and Okada N. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 42 (2006) 625-631
44. Weroha S.J., Li S.A., Tawfik O., and Li J.J. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27 (2006) 491-498
45. Wu M.J., Lian J.D., Yang C.R., Cheng C.H., Chen C.H., Lee W.C., Shu K.H., and Tang M.J. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am. J. Kidney Dis. 43 (2004) 1091-1097
46. Yang C.S., Lin C.H., Chang S.H., and Hsu H.C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 35 (2000) 313-318